A look into the future of the treatments for the common form of the parasitic infection gerd and a range of potential treatments for it is set to be published next month.

While the main objective of the paper, which is published in the journal Science, is to help doctors develop more effective treatments for people with the disease, it also highlights the role of research and the public in making up the scientific community.

It is estimated there are around 2.2 million people with chronic lymphocytic leukemia (CLL) in Australia.

“People are generally quite unaware of the importance of research, and what a huge contribution it has been to the understanding of the disease,” Dr Peter Gorton, chief executive of the National Infertility Coalition, said.

“It’s a really exciting opportunity for the research community to engage the public.”

It’s important for researchers to have a better understanding of what causes the disease.

“If they do, then they will be able to better understand the disease better and therefore be able more effectively to treat it,” Dr Gort on the potential role of the research public in this area.

He said there were many avenues to look at the role they play in research.

“We need to be able of using research and public engagement to improve research and better understand research in a way that is as transparent and accessible as possible,” he said.

Dr Gort said the role the research and scientific community could play was critical.

“When it comes to research and clinical trials, we need to know that what we’re doing is the best way to be treating patients with this disease, not just the most cost-effective, which can be problematic,” he explained.

This article is part of a special issue on gerd therapy for people in Australia, due to be launched on Monday, January 18, 2018.

Follow our coverage of this story, including coverage of: How many people have been treated for chronic lupins?